NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark L. JacobsonCOO2026-09-0310,000$12.95
$129.50kBuy
Mark L. JacobsonCOO2026-09-0310,000$208.65
$2.09MSell
Herriot TabuteauCEO2026-08-064,660$213.95
$997.01kSell
Herriot TabuteauCEO2026-08-064,660$4.95
$23.07kBuy
Herriot TabuteauCEO2026-08-0545,004$4.95
$222.77kBuy
Herriot TabuteauCEO2026-08-0545,004$212.01
$9.54MSell
Herriot TabuteauChief Executive Officer2026-07-0149,666$240.25
$11.93MSell
Herriot TabuteauChief Executive Officer2026-07-0149,666$4.95
$245.85kBuy
Roger JeffsDirector2026-06-11286$249.12
$71.25kSell
Susan MahonyDirector2026-06-10300$246.18
$73.85kSell

1 of 7

AXSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau42.08%22,040,729$4.53BInsider
Antecip Capital LLC14.02%7,344,500$1.51BInsider
Mark Coleman1.59%832,243$171.02MInsider
Roger Jeffs0.20%105,279$21.63MInsider
Nick Pizzie0.08%43,497$8.94MInsider
Curated Wealth Partners LLC0.06%30,000$6.16MInstitution
Mark E. Saad0.02%12,131$2.49MInsider
Randall Kaye0.02%11,044$2.27MInsider
Constance Ames0.01%4,358$895.53kInsider
Blkrok0.01%3,104$637.84kInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM0.07%58.03%Net SellingNet Buying
KRYS0.10%25.15%Net SellingNet Selling
ARWR0.08%9.73%Net SellingNet Selling
KYMR0.12%31.95%Net SellingNet Selling
TECH0.11%2.53%Net SellingNet Selling

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 0.07% institutional shareholders, 58.03% Axsome Therapeutics insiders, and 41.90% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 22.04M shares representing 42.08% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $4.48B.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.